You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,101,866


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,101,866
Title:Anti-inflammatory androstane derivative
Abstract:According to one aspect of the invention, there is provided a compound of formula (I) ##STR00001## and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
Inventor(s): Biggadike; Keith (Stevenage, GB), Coote; Steven John (Stevenage, GB), Nice; Rosalyn Kay (Stevenage, GB)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:09/958,050
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation; Delivery; Use; Process; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,101,866

Introduction

United States Patent 7,101,866, titled "Anti-inflammatory androstane derivatives," is a patent that covers a specific class of compounds, their preparations, and their therapeutic uses. This analysis will delve into the key aspects of this patent, including its scope, claims, and the broader patent landscape.

Patent Overview

The patent, filed by Knobil et al., was granted on September 5, 2006. It pertains to anti-inflammatory androstane derivatives, including their chemical structures, compositions, preparation methods, and therapeutic applications, particularly in treating conditions such as asthma[4].

Scope of the Patent

Claim Construction

When analyzing the scope of a patent, it is crucial to consider the claim construction. Courts typically look at the literal language of the claim, the patent specification, and the prosecution history to determine the scope of the patent claims[2][5].

  • Literal Language of the Claim: The claims in US 7,101,866 define the specific compounds, their structures, and the methods for their preparation and use. For instance, the patent includes claims for compounds of a particular formula and their solvates.
  • Patent Specification: The specification provides detailed descriptions of the invention, including how to make and use the compounds. This ensures that one skilled in the art can replicate the invention, which is a fundamental requirement for patent validity[1].
  • Prosecution History: The history of how the patent was prosecuted, including any amendments or arguments made during the application process, can also influence the interpretation of the claims.

Metrics for Patent Scope

Research has identified metrics such as independent claim length (ICL) and independent claim count (ICC) as useful in measuring patent scope. These metrics can indicate the breadth and clarity of the patent claims. For US 7,101,866, the patent includes 207 claims, which is a significant number, suggesting a detailed and possibly broad scope[3].

Claims Analysis

Types of Claims

The patent includes various types of claims:

  • Composition Claims: These claims cover the chemical compounds themselves and their solvates.
  • Method Claims: These claims cover the processes for preparing the compounds.
  • Use Claims: These claims cover the therapeutic uses of the compounds, such as in treating asthma.

Claim Specificity and Breadth

The specificity and breadth of the claims are critical in defining the patent's scope. Broader claims can provide more extensive protection but may face challenges during the examination process and in litigation. The large number of claims in US 7,101,866 suggests a comprehensive coverage of various aspects of the invention, but it also increases the complexity and potential for disputes over claim interpretation[3].

Patent Landscape

Patent Quality and Scope

The quality and scope of patents have been subjects of debate, particularly in the context of patent litigation and innovation. Patents with overly broad or unclear claims can hinder innovation by increasing licensing and litigation costs. The USPTO has been working to improve patent quality, and metrics such as ICL and ICC are being used to assess and refine the scope of patent claims during the examination process[3].

Litigation and Enforcement

The enforcement of patent claims, especially in the pharmaceutical sector, is often contentious. Courts consider various factors, including the literal language of the claims, the specification, and the prosecution history, to determine the validity and scope of the patent. In cases like GlaxoSmithKline Intellectual Prop. Mgmt. Ltd. v. Sandoz, Inc., these factors are crucial in resolving disputes over patent infringement[5].

Therapeutic Applications

The patent specifically mentions the use of the anti-inflammatory androstane derivatives in therapy, particularly for treating asthma. This therapeutic application is a key aspect of the patent's scope and highlights the practical utility of the invention, which is a requirement for patentability[1].

Economic and Regulatory Implications

Patent Maintenance and Licensing

The maintenance of patents, including payment of fees and potential licensing agreements, can significantly impact the economic viability of the invention. Patents with narrower, clearer claims tend to have a higher probability of grant and shorter examination processes, which can reduce costs and facilitate licensing[3].

Regulatory Compliance

Compliance with regulatory requirements is essential for bringing pharmaceutical products to market. The patent's scope must align with regulatory standards, and any changes in regulatory environments can affect the patent's validity and enforcement.

Key Takeaways

  • Claim Construction: The scope of US 7,101,866 is determined by the literal language of the claims, the patent specification, and the prosecution history.
  • Metrics for Scope: Independent claim length and independent claim count are useful metrics for assessing the breadth and clarity of patent claims.
  • Therapeutic Applications: The patent covers specific therapeutic uses, particularly in treating asthma.
  • Economic and Regulatory Implications: The patent's scope affects its economic viability and regulatory compliance.

FAQs

  1. What is the main subject of United States Patent 7,101,866?

    • The main subject is anti-inflammatory androstane derivatives, including their chemical structures, compositions, preparation methods, and therapeutic applications.
  2. How is the scope of a patent determined?

    • The scope of a patent is determined by the literal language of the claims, the patent specification, and the prosecution history.
  3. What metrics are used to measure patent scope?

    • Metrics such as independent claim length (ICL) and independent claim count (ICC) are used to measure patent scope.
  4. Why is the number of claims in a patent important?

    • The number of claims can indicate the breadth and complexity of the patent, affecting its enforceability and potential for disputes.
  5. How does the patent landscape impact the enforcement of US 7,101,866?

    • The patent landscape, including debates over patent quality and scope, can impact the enforcement of the patent through litigation and regulatory compliance.

Sources

  1. Updating the Patent System's Novelty Requirement to Promote Innovation - University of Illinois College of Law
  2. Wilmin, Delaware - U.S. District Court for the District of Delaware
  3. Patent Claims and Patent Scope - Hoover Institution
  4. United States Patent 7,101,866 B2 - U.S. Patent and Trademark Office
  5. GlaxoSmithKline Intellectual Prop. Mgmt. Ltd. v. Sandoz, Inc. - Vlex Case Law

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,101,866

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,101,866

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0019172Aug 05, 2000
PCT Information
PCT FiledAugust 03, 2001PCT Application Number:PCT/GB01/03495
PCT Publication Date:February 14, 2002PCT Publication Number: WO02/12265

International Family Members for US Patent 7,101,866

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1305329 ⤷  Subscribe 91429 Luxembourg ⤷  Subscribe
European Patent Office 1305329 ⤷  Subscribe CA 2008 00022 Denmark ⤷  Subscribe
European Patent Office 1305329 ⤷  Subscribe 300343 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.